SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001808665-22-000032
Filing Date
2022-05-09
Accepted
2022-05-09 16:51:25
Documents
96
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q asrt-20220331.htm   iXBRL 10-Q 1111528
2 EX-31.1 exhibit311-q12022.htm EX-31.1 11137
3 EX-31.2 exhibit312-q12022.htm EX-31.2 11060
4 EX-32.1 exhibit321-q12022.htm EX-32.1 6027
5 EX-32.2 exhibit322-q12022.htm EX-32.2 6267
  Complete submission text file 0001808665-22-000032.txt   6364997

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20220331.xsd EX-101.SCH 53399
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20220331_cal.xml EX-101.CAL 65676
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20220331_def.xml EX-101.DEF 240973
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20220331_lab.xml EX-101.LAB 574271
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20220331_pre.xml EX-101.PRE 398161
90 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20220331_htm.xml XML 1061399
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

IRS No.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39294 | Film No.: 22905864
SIC: 2834 Pharmaceutical Preparations